{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:14:02Z","timestamp":1794863642936,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61699-w","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T20:59:02Z","timestamp":1754773142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection"],"prefix":"10.1038","volume":"16","author":[{"given":"Yansheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8066-527X","authenticated-orcid":false,"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-7063","authenticated-orcid":false,"given":"Lixu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuohuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baocai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1669-6340","authenticated-orcid":false,"given":"Lianrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-1389","authenticated-orcid":false,"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8965-1015","authenticated-orcid":false,"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"61699_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1473-3099(18)30043-4","volume":"18","author":"O Faye","year":"2018","unstructured":"Faye, O. et al. Genomic characterisation of human monkeypox virus in Nigeria. Lancet Infect. Dis. 18, 246 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"61699_CR2","doi-asserted-by":"publisher","first-page":"e1003756","DOI":"10.1371\/journal.ppat.1003756","volume":"9","author":"SN Shchelkunov","year":"2013","unstructured":"Shchelkunov, S. N. An increasing danger of zoonotic Orthopoxvirus infections. PLoS Pathog. 9, e1003756 (2013).","journal-title":"PLoS Pathog."},{"key":"61699_CR3","doi-asserted-by":"publisher","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","volume":"29","author":"DA Henderson","year":"2011","unstructured":"Henderson, D. A. The eradication of smallpox\u2013an overview of the past, present, and future. Vaccine 29, D7\u2013D9 (2011).","journal-title":"Vaccine"},{"key":"61699_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov, S. N. et al. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509, 66\u201370 (2001).","journal-title":"FEBS Lett."},{"key":"61699_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A Nalca","year":"2010","unstructured":"Nalca, A. & Zumbrun, E. E. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des. Dev. Ther. 4, 71\u201379 (2010).","journal-title":"Drug Des. Dev. Ther."},{"key":"61699_CR6","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.vaccine.2014.02.043","volume":"32","author":"SE Frey","year":"2014","unstructured":"Frey, S. E. et al. Phase II randomized, double-blinded comparison of a single high dose (5\u00d710(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1\u00d710(8) TCID50) in healthy vaccinia-na\u00efve individuals. Vaccine 32, 2732\u20132739 (2014).","journal-title":"Vaccine"},{"key":"61699_CR7","doi-asserted-by":"publisher","first-page":"eadl4317","DOI":"10.1126\/scitranslmed.adl4317","volume":"16","author":"C Jacob-Dolan","year":"2024","unstructured":"Jacob-Dolan, C. et al. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci. Transl. Med. 16, eadl4317 (2024).","journal-title":"Sci. Transl. Med."},{"key":"61699_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6404a1","volume":"64","author":"BW Petersen","year":"2015","unstructured":"Petersen, B. W. et al. Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm. Rep. 64, 1\u201326 (2015).","journal-title":"MMWR Recomm. Rep."},{"key":"61699_CR9","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1128\/AAC.00208-15","volume":"59","author":"A Berhanu","year":"2015","unstructured":"Berhanu, A. et al. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrob. Agents Chemother. 59, 4296\u20134300 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"61699_CR10","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1016\/j.vaccine.2013.04.050","volume":"31","author":"SE Frey","year":"2013","unstructured":"Frey, S. E. et al. Safety and immunogenicity of IMVAMUNE\u00ae smallpox vaccine using different strategies for a post event scenario. Vaccine 31, 3025\u20133033 (2013).","journal-title":"Vaccine"},{"key":"61699_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines - a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61699_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou, F. et al. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat. Commun. 14, 5925 (2023).","journal-title":"Nat. Commun."},{"key":"61699_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang, Y. et al. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct. Target Ther. 8, 172 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"61699_CR14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/nm1457","volume":"12","author":"MM P\u00fctz","year":"2006","unstructured":"P\u00fctz, M. M., Midgley, C. M., Law, M. & Smith, G. L. Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat. Med. 12, 1310\u20131315 (2006).","journal-title":"Nat. Med."},{"key":"61699_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.virusres.2004.08.015","volume":"106","author":"GL Smith","year":"2004","unstructured":"Smith, G. L. & Law, M. The exit of vaccinia virus from infected cells. Virus Res. 106, 189\u2013197 (2004).","journal-title":"Virus Res."},{"key":"61699_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000322101","volume":"37","author":"G Pauli","year":"2010","unstructured":"Pauli, G. et al. Orthopox viruses: infections in humans. Transfus. Med. Hemother. 37, 351\u2013364 (2010).","journal-title":"Transfus. Med. Hemother."},{"key":"61699_CR17","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.str.2015.04.023","volume":"23","author":"RM Cou\u00f1ago","year":"2015","unstructured":"Cou\u00f1ago, R. M. et al. Structures of Orf virus chemokine binding protein in complex with host chemokines reveal clues to broad binding specificity. Structure 23, 1199\u20131213 (2015).","journal-title":"Structure"},{"key":"61699_CR18","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","volume":"72","author":"RL Roper","year":"1998","unstructured":"Roper, R. L., Wolffe, E. J., Weisberg, A. & Moss, B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72, 4192\u20134204 (1998).","journal-title":"J. Virol."},{"key":"61699_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","volume":"72","author":"CS Chung","year":"1998","unstructured":"Chung, C. S., Hsiao, J. C., Chang, Y. S. & Chang, W. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72, 1577\u20131585 (1998).","journal-title":"J. Virol."},{"key":"61699_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jmb.2005.04.024","volume":"349","author":"Y Ho","year":"2005","unstructured":"Ho, Y. et al. The oligomeric structure of vaccinia viral envelope protein A27L is essential for binding to heparin and heparan sulfates on cell surfaces: a structural and functional approach using site-specific mutagenesis. J. Mol. Biol. 349, 1060\u20131071 (2005).","journal-title":"J. Mol. Biol."},{"key":"61699_CR21","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1128\/JVI.00353-08","volume":"82","author":"DR Kaufman","year":"2008","unstructured":"Kaufman, D. R. et al. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice. J. Virol. 82, 6829\u20136837 (2008).","journal-title":"J. Virol."},{"key":"61699_CR22","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1128\/JVI.79.13.8046-8056.2005","volume":"79","author":"WL Chiu","year":"2005","unstructured":"Chiu, W. L., Szajner, P., Moss, B. & Chang, W. Effects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly. J. Virol. 79, 8046\u20138056 (2005).","journal-title":"J. Virol."},{"key":"61699_CR23","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1128\/JVI.76.19.9575-9587.2002","volume":"76","author":"WL Chiu","year":"2002","unstructured":"Chiu, W. L. & Chang, W. Vaccinia virus J1R protein: a viral membrane protein that is essential for virion morphogenesis. J. Virol. 76, 9575\u20139587 (2002).","journal-title":"J. Virol."},{"key":"61699_CR24","doi-asserted-by":"publisher","first-page":"932388","DOI":"10.3389\/fimmu.2022.932388","volume":"13","author":"MW Dahlgren","year":"2022","unstructured":"Dahlgren, M. W. et al. Type I interferons promote germinal centers through B cell intrinsic signaling and dendritic cell dependent Th1 and Tfh cell lineages. Front. Immunol. 13, 932388 (2022).","journal-title":"Front. Immunol."},{"key":"61699_CR25","doi-asserted-by":"publisher","first-page":"Suppl, A66","DOI":"10.1093\/infdis\/133.Supplement_2.A66","volume":"133","author":"P Lindahl","year":"1976","unstructured":"Lindahl, P., Gresser, I., Leary, P. & Tovey, M. Enhanced expression of histocompatibility antigens of lymphoid cells in mice treated with interferon. J. Infect. Dis. 133, Suppl, A66\u201368 (1976).","journal-title":"J. Infect. Dis."},{"key":"61699_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1073\/pnas.73.4.1284","volume":"73","author":"P Lindahl","year":"1976","unstructured":"Lindahl, P., Gresser, I., Leary, P. & Tovey, M. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc. Natl. Acad. Sci. USA 73, 1284\u20131287 (1976).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61699_CR27","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","volume":"174","author":"JM Curtsinger","year":"2005","unstructured":"Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. & Mescher, M. F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174, 4465\u20134469 (2005).","journal-title":"J. Immunol."},{"key":"61699_CR28","doi-asserted-by":"publisher","first-page":"943334","DOI":"10.3389\/fimmu.2022.943334","volume":"13","author":"LS Nolan","year":"2022","unstructured":"Nolan, L. S. & Baldridge, M. T. Advances in understanding interferon-mediated immune responses to enteric viruses in intestinal organoids. Front. Immunol. 13, 943334 (2022).","journal-title":"Front. Immunol."},{"key":"61699_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375\u2013386 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"61699_CR30","doi-asserted-by":"publisher","first-page":"101277","DOI":"10.1016\/j.smim.2019.05.001","volume":"43","author":"S Lukhele","year":"2019","unstructured":"Lukhele, S., Boukhaled, G. M. & Brooks, D. G. Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin. Immunol. 43, 101277 (2019).","journal-title":"Semin. Immunol."},{"key":"61699_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20050821","volume":"202","author":"GA Kolumam","year":"2005","unstructured":"Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.  J. Exp. Med. 202, 637\u2013650 (2005).","journal-title":"J. Exp. Med."},{"key":"61699_CR32","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1016\/j.vaccine.2006.02.011","volume":"24","author":"S de Avila Botton","year":"2006","unstructured":"de Avila Botton, S. et al. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24, 3446\u20133456 (2006).","journal-title":"Vaccine"},{"key":"61699_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jviromet.2007.07.016","volume":"146","author":"W Jiang","year":"2007","unstructured":"Jiang, W., Ren, L. & Jin, N. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha. J. Virol. Methods 146, 266\u2013273 (2007).","journal-title":"J. Virol. Methods"},{"key":"61699_CR34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1099\/vir.0.006833-0","volume":"90","author":"L O\u2019Brien","year":"2009","unstructured":"O\u2019Brien, L. et al. Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection. J. Gen. Virol. 90, 874\u2013882 (2009).","journal-title":"J. Gen. Virol."},{"key":"61699_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2567.2006.02506.x","volume":"120","author":"CK Tang","year":"2007","unstructured":"Tang, C. K. et al. Mannan-mediated gene delivery for cancer immunotherapy. Immunology 120, 325\u2013335 (2007).","journal-title":"Immunology"},{"key":"61699_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.bbrc.2004.03.141","volume":"317","author":"Y Hattori","year":"2004","unstructured":"Hattori, Y., Kawakami, S., Suzuki, S., Yamashita, F. & Hashida, M. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. 317, 992\u2013999 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"61699_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1124\/jpet.106.105098","volume":"318","author":"Y Hattori","year":"2006","unstructured":"Hattori, Y., Kawakami, S., Nakamura, K., Yamashita, F. & Hashida, M. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route.  J. Pharmacol. Exp. Ther. 318, 828\u2013834 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"61699_CR38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani, A. et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from Orthopoxvirus disease. Cell 187, 1363\u20131373.e1312 (2024).","journal-title":"Cell"},{"key":"61699_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1515\/BC.2007.061","volume":"388","author":"O Boehm","year":"2007","unstructured":"Boehm, O. et al. Clinical chemistry reference database for Wistar rats and C57\/BL6 mice. Biol. Chem. 388, 547\u2013554 (2007).","journal-title":"Biol. Chem."},{"key":"61699_CR40","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1590\/0001-3765201820180586","volume":"90","author":"DP Fernandes","year":"2018","unstructured":"Fernandes, D. P. et al. Hematological and biochemical profile of BALB\/c nude and C57BL\/6 SCID female mice after ovarian xenograft. An. da Acad. Bras. de Cienc. 90, 3941\u20133948 (2018).","journal-title":"An. da Acad. Bras. de Cienc."},{"key":"61699_CR41","first-page":"46","volume":"42","author":"LM Serfilippi","year":"2003","unstructured":"Serfilippi, L. M., Pallman, D. R. & Russell, B. Serum clinical chemistry and hematology reference values in outbred stocks of albino mice from three commonly used vendors and two inbred strains of albino mice. Contemp. Top. Lab. Anim. Sci. 42, 46\u201352 (2003).","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"61699_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0952-7915(00)00180-1","volume":"13","author":"C Th\u00e9ry","year":"2001","unstructured":"Th\u00e9ry, C. & Amigorena, S. The cell biology of antigen presentation in dendritic cells. Curr. Opin. Immunol. 13, 45\u201351 (2001).","journal-title":"Curr. Opin. Immunol."},{"key":"61699_CR43","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1128\/JVI.02052-06","volume":"81","author":"FS Quan","year":"2007","unstructured":"Quan, F. S., Huang, C., Compans, R. W. & Kang, S. M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 81, 3514\u20133524 (2007).","journal-title":"J. Virol."},{"key":"61699_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0952-7915(98)80162-3","volume":"10","author":"MK Slifka","year":"1998","unstructured":"Slifka, M. K. & Ahmed, R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10, 252\u2013258 (1998).","journal-title":"Curr. Opin. Immunol."},{"key":"61699_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.virs.2024.01.004","volume":"39","author":"L Cheng","year":"2024","unstructured":"Cheng, L. et al. Isolation and characterization of mpox virus from the first mpox case in Shenzhen, China. Virol. Sin. 39, 335\u2013337 (2024).","journal-title":"Virol. Sin."},{"key":"61699_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","volume":"13","author":"JL Xu","year":"2000","unstructured":"Xu, J. L. & Davis, M. M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13, 37\u201345 (2000).","journal-title":"Immunity"},{"key":"61699_CR47","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1073\/pnas.1403684111","volume":"111","author":"SA Valkenburg","year":"2014","unstructured":"Valkenburg, S. A. et al. IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection. Proc. Natl. Acad. Sci. USA 111, 5676\u20135681 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61699_CR48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jgg.2023.04.012","volume":"50","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Microbiota-mediated shaping of mouse spleen structure and immune function characterized by scRNA-seq and Stereo-seq. J. Genet. Genom.50, 688\u2013701 (2023).","journal-title":"J. Genet. Genom."},{"key":"61699_CR49","doi-asserted-by":"publisher","first-page":"e28174","DOI":"10.1002\/jmv.28174","volume":"95","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Influenza vaccination features revealed by a single-cell transcriptome atlas. J. Med Virol. 95, e28174 (2023).","journal-title":"J. Med Virol."},{"key":"61699_CR50","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","volume":"6","author":"I Voskoboinik","year":"2006","unstructured":"Voskoboinik, I., Smyth, M. J. & Trapani, J. A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6, 940\u2013952 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"61699_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","volume":"131","author":"K Pieper","year":"2013","unstructured":"Pieper, K., Grimbacher, B. & Eibel, H. B-cell biology and development.  J. Allergy Clin. Immunol. 131, 959\u2013971 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"61699_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","volume":"566","author":"B Briney","year":"2019","unstructured":"Briney, B., Inderbitzin, A., Joyce, C. & Burton, D. R. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature 566, 393\u2013397 (2019).","journal-title":"Nature"},{"key":"61699_CR53","doi-asserted-by":"publisher","first-page":"W202","DOI":"10.1093\/nar\/gkp335","volume":"37","author":"TL Bailey","year":"2009","unstructured":"Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202\u2013W208 (2009).","journal-title":"Nucleic Acids Res."},{"key":"61699_CR54","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","volume":"114","author":"HS Robins","year":"2009","unstructured":"Robins, H. S. et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114, 4099\u20134107 (2009).","journal-title":"Blood"},{"key":"61699_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41421-024-00739-z","volume":"10","author":"L Cheng","year":"2024","unstructured":"Cheng, L. et al. Pathogenic BALB\/c mice infection model for evaluation of mpox countermeasures. Cell Discov. 10, 105 (2024).","journal-title":"Cell Discov."},{"key":"61699_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2016.10.009","volume":"313","author":"G Zhang","year":"2016","unstructured":"Zhang, G. et al. Up-regulation of granzyme B and perforin by staphylococcal enterotoxin C2 mutant induces enhanced cytotoxicity in Hepa1-6 cells. Toxicol. Appl. Pharmacol. 313, 1\u20139 (2016).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"61699_CR57","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","volume":"32","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Mol. Ther. J. Am. Soc. Gene Ther. 32, 1779\u20131789 (2024).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"61699_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54941-4","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Aberrant METTL1-mediated tRNA m(7)G modification alters B-cell responses in systemic autoimmunity in humans and mice. Nat. Commun. 15, 10599 (2024).","journal-title":"Nat. Commun."},{"key":"61699_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang, H. Sample size determination and power analysis using the G*Power software. J. Educ. Eval. Health Prof. 18, 17 (2021).","journal-title":"J. Educ. Eval. Health Prof."},{"key":"61699_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70901-w","volume":"14","author":"MF Iparraguirre Nu\u00f1overo","year":"2024","unstructured":"Iparraguirre Nu\u00f1overo, M. F. et al. The effect of intracanal cryotherapy with and without foraminal enlargement on pain prevention after endodontic treatment: a randomized clinical trial. Sci. Rep. 14, 19905 (2024).","journal-title":"Sci. Rep."},{"key":"61699_CR61","doi-asserted-by":"publisher","first-page":"e66276","DOI":"10.1371\/journal.pone.0066276","volume":"8","author":"W Meng","year":"2013","unstructured":"Meng, W. et al. Rapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases. PLoS ONE 8, e66276 (2013).","journal-title":"PLoS ONE"},{"key":"61699_CR62","doi-asserted-by":"publisher","first-page":"e71725","DOI":"10.7554\/eLife.71725","volume":"10","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection. eLife 10, e71725 (2021).","journal-title":"eLife"},{"key":"61699_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcv.2006.03.012","volume":"36","author":"Y Li","year":"2006","unstructured":"Li, Y., Olson, V. A., Laue, T., Laker, M. T. & Damon, I. K. Detection of monkeypox virus with real-time PCR assays. J. Clin. Virol. 36, 194\u2013203 (2006).","journal-title":"J. Clin. Virol."},{"key":"61699_CR64","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.4049\/jimmunol.2000538","volume":"205","author":"X Fu","year":"2020","unstructured":"Fu, X. et al. Staphylococcal enterotoxin C2 mutant-directed fatty acid and mitochondrial energy metabolic programs regulate CD8(+) T cell activation. J. Immunol. 205, 2066\u20132076 (2020).","journal-title":"J. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61699-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:55:50Z","timestamp":1757346950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61699"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61699-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors S.C., S.Y.L., and L.W. have filed a Chinese patent application (number: 202410069336.7) for the MPXV mRNA vaccines and their construction method and application. The other authors do not claim competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7373"}}